Valens' distribution network now includes five
Canadian provinces with additional expansion expected in the
short-term
KELOWNA, BC, April 7, 2021 /CNW/ - The Valens Company
Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The
Valens Company" or "Valens"), a leading
manufacturer of cannabis products, today announced that it has
entered into an agreement with the Manitoba Liquor & Lotteries
Corporation to supply and distribute a wide range of cannabis
products to LGCA-licensed private retailers in the Province of
Manitoba. With this agreement,
Valens expands its distribution network to five provinces in the
country.
"Expanding our domestic distribution capabilities is one of our
top strategic initiatives to drive growth this year and beyond,"
said Tyler Robson, Chief Executive
Officer, Co-Founder and Chair of The Valens Company. "Our entry
into the Manitoba market takes us
a step further toward capturing larger market share and bringing
the Valens advantage to consumers in a new province, enabling
greater access to our high-quality products across Canada."
Valens has already shipped several products to the province,
including A1 Cannabis' Summit 10 THC beverages, Verse Cannabis'
Tropic Lemon and Sunset Peach vape carts and 1:20 CBD oil, with
additional product formats across various categories expected to be
shipped in the coming weeks.
In addition to Manitoba, the
Company's distribution network also includes Alberta, British
Columbia, Ontario and
Saskatchewan. Expansion into
other Canadian provinces and territories, such as Quebec, is expected in the short-term as
discussions continue with provincial and territorial boards and
private retailers.
About The Valens Company
The Valens Company is a leading manufacturer of cannabis
products with a mission to bring the benefits of cannabis to the
world. The Company provides proprietary cannabis processing
services across five core technologies, in addition to
best-in-class product development, formulation and manufacturing of
cannabis consumer packaged goods. The Valens Company's high-quality
products are exclusively formulated for the medical, therapeutic,
health and wellness, and recreational consumer segments, and are
offered across numerous product formats, including oils, vapes,
concentrates, edibles and topicals, as well as pre-rolls, with a
focus on next-generation product development and innovation. Its
breakthrough patented emulsification technology, SōRSE™ by Valens,
converts cannabis oil into water-soluble emulsions for seamless
integration into a variety of product formats, allowing for
near-perfect dosing, stability, and taste. In partnership with
brand houses, consumer packaged goods companies and licensed
cannabis producers around the globe, the Company continues to grow
its diverse product portfolio in alignment with evolving cannabis
consumer preferences in key markets. Through its wholly owned
subsidiary Valens Labs Ltd., the Company is setting the standard in
cannabis testing and research and development with Canada's only ISO17025 accredited analytical
services lab, named The Centre of Excellence in Plant-Based Science
by partner and scientific world leader Thermo Fisher Scientific.
Discover more on The Valens Company and its subsidiaries
at http://www.thevalenscompany.com.
Notice regarding Forward Looking Statements
All information included in this press release, including any
information as to the future financial or operating performance and
other statements of The Valens Company that express management's
expectations or estimates of future performance, other than
statements of historical fact, constitute forward-looking
information or forward-looking statements within the meaning of
applicable securities laws and are based on expectations, estimates
and projections as of the date hereof. Forward-looking statements
are included for the purpose of providing information about
management's current expectations and plans relating to the future.
Wherever possible, words such as "plans", "expects", "scheduled",
"trends", "indications", "potential", "estimates", "predicts",
"anticipate", "to establish", "believe", "intend", "ability to", or
statements that certain actions, events or results "may", "could",
"would", "might", "will", or are "likely" to be taken, occur or be
achieved, or the negative of these words or other variations
thereof, have been used to identify such forward-looking
information. Specific forward-looking statements include, without
limitation, all disclosure regarding future results of operations,
economic conditions and anticipated courses of action.
The risks and uncertainties that may affect forward-looking
statements include, among others, regulatory risk, United States border crossing and travel bans,
reliance on licenses, expansion of facilities, competition,
dependence on supply of cannabis and reliance on other key inputs,
dependence on senior management and key personnel, general business
risk and liability, regulation of the cannabis industry, change in
laws, regulations and guidelines, compliance with laws, reliance on
a single facility, limited operating history, vulnerability to
rising energy costs, unfavourable publicity or consumer perception,
product liability, risks related to intellectual property, product
recalls, difficulties with forecasts, management of growth and
litigation, many of which are beyond the control of The Valens
Company. For a more comprehensive discussion of the risks faced by
The Valens Company, and which may cause the actual financial
results, performance or achievements of The Valens Company to be
materially different from estimated future results, performance or
achievements expressed or implied by forward-looking information or
forward-looking statements, please refer to The Valens Company's
latest Annual Information Form filed with Canadian securities
regulatory authorities at www.sedar.com or on The Valens Company's
website at www.thevalenscompany.com. The risks described in such
Annual Information Form are hereby incorporated by reference
herein. Although the forward-looking statements contained herein
reflect management's current beliefs and reasonable assumptions
based upon information available to management as of the date
hereof, The Valens Company cannot be certain that actual results
will be consistent with such forward-looking information. The
Valens Company cautions you not to place undue reliance upon any
such forward-looking statements. The Valens Company disclaims any
intention or obligation to update or revise any forward-looking
statements whether as a result of new information, future events or
otherwise, except as required by applicable law. Nothing herein
should be construed as either an offer to sell or a solicitation to
buy or sell securities of The Valens Company.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/the-valens-company-expands-cannabis-distribution-network-with-entry-into-manitoba-market-301264551.html
SOURCE The Valens Company Inc.